Assoc. of Pulmonary Advanced Practice Providers

Corinne Young discusses bronchiectasis with expert NP Jennifer Faber-Gerling to shed light on this chronic respiratory condition. Learn more about the complexities of bronchiectasis on our YouTube channel youtu.be/KMhzLtmcHGY. 🎙️ 🎧

Don't forget nominations for Provider of the Year, Rising Star, or Mentor of the Year are due tomorrow, April 1st! Know an APAPP member who is doing excellent work in our field? Nominate them at the link. 🏆 forms.gle/duuuq7qakD9hNi…

We are thrilled to announce that Dr. Justine Sicari, DNP, FNP-C, MSN, and Brian Bizik, MS, PA-C, DFAAPA, are the new COPD Committee Co-Chairs. Learn more about them and what they have planned on the link. heyor.ca/ngf7xV

Interested in joining the APAPP Board of Directors? We have two positions opening in April, Secretary and Treasurer. Submissions are due April 30th, application available here forms.gle/QiTydoD9QgyCyr…

Biologics and Zephyr Valves target different COPD phenotypes and disease drivers and should not be viewed as competing therapies. Review patient selection and treatment pathways using the GOLD 2026 COPD Assessment tool. See how they can be used at the link pulmonx.com

Order Biodesix Nodify CDT® testing for patients with nodules as small as 4 mm* following the latest Biodesix clinical validation study, which includes more than 1,100 patients. Contact Marketing@Biodesix.com to obtain the "nodule size ruler" tool to aid in patient discussions.

Brian Bizik and @[Corinne Young](urn:li:person:OUer-x1Blo)<corinne-young-2bb8a824> dive into the 2026 GOLD COPD updates in our March APAPP Podcast episode! Learn about treatment guidelines and more at youtube.com/watch?v=NaX7it…🎧

You do not want to miss the 3rd Annual APAPP National Conference! 𝗘𝗮𝗿𝗹𝘆 𝗕𝗶𝗿𝗱 𝗥𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗘𝗻𝗱𝘀 𝗧𝗼𝗱𝗮𝘆, 𝗠𝗮𝗿𝗰𝗵 𝟭𝟲𝘁𝗵! All conference information is available at pulmapplive.com

Tune in to our YouTube (youtu.be/8RjuzRh04j0) to hear from Vincent DeRienzo, PA-C, Ambera Dedic, DNP, ARNP, FNP-C, and Greg McClelland, PA-C, AE-C as they discuss corticosteroid use across the lifespan. 🎧

This message is sponsored by @sanofi and @regeneron Discover the Difference at this year’s @atscommunity Congress in Orlando, Florida. Prescribing Information at regeneron.com/downloads/dupi…

We are looking for dedicated members to join our Bronchiectasis Committee. This is a unique opportunity to focus on a specialized area of pulmonary health to contribute to education and patient advocacy. 🫁  Send an email of interest to info@pulmapp.com

Know an APAPP member who is doing excellent work in our field? Nominate them for a Provider of the Year, Rising Star, or Mentor of the Year award on the link by April 1st. 🏆 forms.gle/duuuq7qakD9hNi…

Antifibrotic therapy for interstitial lung disease is shifting from a narrow, IPF- only focus with two modestly effective drugs to a broader, more patient-centered, and potentially better set of options that span multiple progressive pulmonary fibrosis. ⚕️ heyor.ca/bjZw1d

Treat patients with #COPD? Free #CME #CE offers the latest insights on biologics, including GOLD guidelines, trial data, and more. Provided by NACE in partnership with APAPP. Available on @mycme at heyor.ca/FzMiK0

Join @[Corinne Young](urn:li:person:OUer-x1Blo)<corinne-young-2bb8a824>, President of APAPP, as she hosts Brian Bizik, a seasoned PA and respiratory care coordinator, as they discuss the 2026 Gold Guidelines in our most recent podcast episode.🎧 youtube.com/watch?v=NaX7it…

Looking for info on treating Narcolepsy and Idiopathic Hypersomnia? Tune in to one or all virtual programs from Jazz Pharmaceuticals at sleepspotlights.com

Want to present at CHEST 2026 on behalf of APAPP? CHEST will be in Phoenix this year, 10/18-10/21. Submissions are due by March 31, 2026, at heyor.ca/BwRjK0 📆  Please email info@pulmapp.com if you have questions. @accpchest

Are you ready to lead? We are seeking a visionary to serve as the next Chair of the Critical Care Committee. 🫀  Position Opens: June 2026 Application Deadline: February 28, 2026 Apply at heyor.ca/aU509M Questions? Contact Rhea Votipka at RheaVotipka@gmail.com.

Patients with varying severity of symptoms can benefit from Zephyr Valve treatment — even those who have just begun limiting their activities due to breathlessness. Download the full Patient Selection Criteria at heyor.ca/I1q1cN @zephyrbypulmonx

🎉 We’re excited to share Fibrosis on the Frontlines: What Every NP/PA Needs to Know About Managing Patients With Fibrosing ILDs- created in partnership with @DeceraClinEdu heyor.ca/98Yh74